<DOC>
	<DOC>NCT01930565</DOC>
	<brief_summary>In an 8 week double blind randomized controlled split-face studies, we tried to compare the clinical efficacy, safety and histopathological changes between Lactobacillus fermented Chamaecypris obtusa (LFCO) and existing tea tree oil (TTO) Basically, this is a split face study - one side of face randomly assigned was applied with LFCO and the other side with TTO in same patients.</brief_summary>
	<brief_title>Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study</brief_title>
	<detailed_description>Screening of natural compounds for the development of anti-acne therapeutic agents has been steadily required considering various side effects of acne medications.However, previous studies have mainly focused on experimental tests without clinical trials and histopathological analysis. To compare the clinical efficacy, safety and histopathological changes between Lactobacillus fermented Chamaecypris obtusa (LFCO) and existing tea tree oil (TTO) Total thirty four patients were instructed to apply 5 % LFCO to the involved areas of randomly allocated side and 5 % TTO extract to the other side for 8 weeks in a double blind split-face clinical trial.</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Tea Tree Oil</mesh_term>
	<criteria>age 1945 active acne lesions in both sides of face available during study periods pregnancy, mental illness, intake of oral isotretinoin within 6 months, application of the other oral or topical acne medications, chemical peeling or light based treatments within 6 weeks.</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>acne</keyword>
	<keyword>therapeutics</keyword>
	<keyword>clinical trial</keyword>
	<keyword>natural compound</keyword>
	<keyword>Lactobacillus fermented Chamaecypris obtuse</keyword>
	<keyword>tea tree oil</keyword>
</DOC>